Search

everythinglearnresearchcommunity

for

Search:↓

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Excess androgens may cause PCOS, not just be a symptom.

High testosterone increases heart disease risk in women with PCOS.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.